Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Liver transplantation--economics in the less developed world.

Saigal S, Shah SR.

Indian J Gastroenterol. 2012 Jan;31(1):13-4. doi: 10.1007/s12664-011-0159-8. Epub 2012 Jan 7. No abstract available.

PMID:
22228318
2.

Cost and efficacy of immunosuppression using generic products following living donor liver transplantation in India.

Sudhindran S, Aboobacker S, Menon RN, Unnikrishnan G, Sudheer OV, Dhar P.

Indian J Gastroenterol. 2012 Jan;31(1):20-3. doi: 10.1007/s12664-011-0138-0. Epub 2011 Dec 23.

PMID:
22194185
3.

Cost of liver transplantation using tacrolimus.

McAlister VC, Peltekian K, Bitter-Suermann H, MacDonald AS, Beaudry L.

Transplant Proc. 1998 Jun;30(4):1502. No abstract available.

PMID:
9636611
4.

Costs of immunosuppressive therapies used in renal transplantation.

Barclay PG, Allen RD, Stewart JH, Ng K, Chapman JR.

Transplant Proc. 1992 Feb;24(1):165-6. No abstract available.

PMID:
1539225
5.
6.

Risking life to give life.

Carmichael M.

Newsweek. 2002 Apr 22;139(16):53. No abstract available.

PMID:
11974395
7.

Is living donor liver transplantation cost-effective?

Sagmeister M, Müllhaupt B.

J Hepatol. 2005 Jul;43(1):27-32. Review. No abstract available.

PMID:
15922477
8.

Cost of a quality-adjusted life year in liver transplantation: the influence of the indication and the model for end-stage liver disease score.

Åberg F, Mäklin S, Räsänen P, Roine RP, Sintonen H, Koivusalo AM, Höckerstedt K, Isoniemi H.

Liver Transpl. 2011 Nov;17(11):1333-43. doi: 10.1002/lt.22388.

9.

Evaluating strategies for reducing the costs of immunosuppression.

Gorman KJ.

Liver Transpl Surg. 1999 Jul;5(4 Suppl 1):S115-21. No abstract available.

10.

The economics of immunosuppression in renal transplantation: a review of recent literature.

Hutton J.

Transplant Proc. 1999 Feb-Mar;31(1-2):1328-32. Review. No abstract available.

PMID:
10083592
11.

Analysis of cost-effectiveness and cost-utility for immunosuppressive protocols in renal transplantation.

Keown P.

Transplant Proc. 1999 Feb-Mar;31(1-2):1140-1. No abstract available.

PMID:
10083510
12.

Immunosuppression in living related and living unrelated liver transplantation.

Janssen H, Malagó M, Testa G, Broelsch CE.

Transplant Proc. 2002 Jun;34(4):1229-30. No abstract available.

PMID:
12072324
13.

[Liver donors no longer foot the bill Compensation for medical costs and loss of income].

Hubben JH, Slooff MJ.

Ned Tijdschr Geneeskd. 2010;154:A1820. Dutch.

PMID:
20482907
15.

Liver transplantation costs in the era of a health care crisis: Are we looking beyond and thinking about the economics?

Haque M.

Liver Transpl. 2010 Apr;16(4):534; author reply 535. doi: 10.1002/lt.22023. No abstract available.

16.

The cost of rejection in liver allograft recipients.

Martin JE, Fleck P, Schroeder TJ, Whiting JF, Hanto DW.

Transplant Proc. 1998 Jun;30(4):1500-1. No abstract available.

PMID:
9636610
17.

The impact of immunosuppressive regimens on the cost of liver transplantation--results from the U.S. FK506 multicenter trial.

Lake JR, Gorman KJ, Esquivel CO, Wiesner RH, Klintmalm GB, Miller CM, Shaw BW, Gordon JA.

Transplantation. 1995 Nov 27;60(10):1089-95.

PMID:
7482713
18.

Living-donor liver transplantation for chronic hepatic graft-versus-host disease.

Shimizu T, Kasahara M, Tanaka K.

N Engl J Med. 2006 Apr 6;354(14):1536-7. No abstract available.

19.

A comparative study of resource use and costs of renal, liver and heart transplantation.

Oostenbrink JB, Kok ET, Verheul RM.

Transpl Int. 2005 Apr;18(4):437-43.

20.

Minimal but essential doses of immunosuppression: a more realistic approach to improve long-term outcomes for pediatric living-donor liver transplantation.

Ohe H, Li Y, Nafady-Hego H, Kayo W, Sakaguchi S, Wood K, Calne R, Uemoto S, Koshiba T.

Transplantation. 2011 Apr 15;91(7):808-10. doi: 10.1097/TP.0b013e31820f07de. No abstract available.

PMID:
21436656

Supplemental Content

Support Center